Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

Healthcare Biotechnology
"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

BioExx Specialty Proteins Ltd > Q4 conference call
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by fjrmotoon Aug 03, 2012 12:15pm
235 Views
Post# 20181516

RE: RE: RE: Q4 conference call

RE: RE: RE: Q4 conference call

Anyone with a minimal understanding of BXI already knows how close to the edge this company has been financially and how important the final GEA report providing unequivocal confirmation on the viability of BXI's science and technology was. Now that we have this expert, independant third party confirmation, Bioexx will be  looked at in a much more favorable light from those that can provide short term financing as well as capital expense financing for project buildout IMO. THe light at the end of the tunnel is no longer a train approaching!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities